A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) ± lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948)

Metadata

Item Type:	Article
Authors/Creators:	Smyth, E Rowley, S Allum, W Stenning, S Wotherspoon, A Robb, C Grabsch, H https://orcid.org/0000-0001-9520-6228 Alderson, D Crosby, T Mason, R Griffin, M Mansoor, W Darby, S Seymour, M https://orcid.org/0000-0002-2441-9629 Thompson, J Sothi, S Sumpter, K Blazeby, J Langley, R Cunningham, D
Dates:	Published (online): 13 October 2016 Published: 1 October 2016
Institution:	The University of Leeds
Academic Units:	The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Clinical Cancer Research (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Pathology & Tumour Biology (Leeds)
Depositing User:	Symplectic Publications
Date Deposited:	27 Nov 2018 14:46
Last Modified:	27 Nov 2018 14:46
Status:	Published
Publisher:	Oxford University Press
Identification Number:	10.1093/annonc/mdw435.17
Open Archives Initiative ID (OAI ID):	oai:eprints.whiterose.ac.uk:139213

CORE (COnnecting REpositories)